Welcome to our dedicated page for Butterfly Network news (Ticker: BFLY), a resource for investors and traders seeking the latest updates and insights on Butterfly Network stock.
Butterfly Network, Inc. (BFLY) is revolutionizing the healthcare landscape with its innovative digital health solutions, primarily focused on handheld, whole-body ultrasound technology. The company, which operates at the nexus of advanced engineering and scientific disciplines, has assembled a team of world-class talents in computer science, physics, and electrical engineering. Underpinned by a robust financial foundation from a select group of highly successful serial entrepreneurs, Butterfly Network is uniquely positioned to dedicate its full attention to product and intellectual property development.
Butterfly Network's flagship product, the Butterfly iQ+, represents a significant leap in medical imaging technology. This compact, user-friendly device leverages the company's proprietary Ultrasound-on-Chip technology to enable healthcare professionals to perform comprehensive whole-body imaging using a single handheld probe. The device's affordability and portability make it a game-changer in clinical settings, ensuring that high-quality ultrasound imaging is accessible and practical for a wide range of medical applications.
The integration of cloud-connected software with hardware technology further enhances the utility of the Butterfly iQ+, allowing for seamless data acquisition and analysis via a mobile application. This connectivity facilitates the practical application of ultrasound information within clinical workflows, thereby improving diagnostic capabilities and patient outcomes.
Recent achievements and ongoing projects include advancements in ultrasound technology and the expansion of the product's applications in various medical fields. The company's commitment to innovation is reflected in its continuous efforts to enhance the performance and capabilities of its devices.
With a strong focus on R&D and a strategic approach to technological development, Butterfly Network is poised to make significant contributions to digital health and medical imaging. The company's progress and updates can be closely followed through the latest news and press releases, which provide valuable insights into its performance, events, and developments.
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld whole-body ultrasound technology, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The conference will take place from January 13-16, 2025, at the Westin St. Francis in San Francisco.
President, CEO & Chairman Joseph DeVivo and EVP & CFO Heather Getz will present on January 16, 2025, at 7:30 AM PST. The presentation will be available via webcast on the Events & Presentations section of Butterfly's investor website and will remain accessible for replay until February 15, 2025.
Butterfly Network (NYSE: BFLY) has announced its participation in the upcoming virtual BTIG Digital Health Forum on November 25, 2024. The company's leadership will engage in two key presentations: a 9:00 AM ET Fireside Chat featuring CEO Joseph DeVivo and CFO Heather Getz discussing Butterfly's technology and strategy, and a 3:00 PM ET Panel Discussion where CMO Dr. John Martin will explore the impact of tools like Butterfly iQ3 on diagnostic and treatment approaches. One-on-one meetings with executives can be arranged through BTIG representatives.
Butterfly Network's iQ3™ handheld ultrasound device has won the Best Medical Technology Award at the 2024 Prix Galien USA Awards, often referred to as the 'Nobel Prize of Life Sciences.' The third-generation device, built on Butterfly's proprietary P4.3 semiconductor platform, represents a significant advancement in ultrasound technology with enhanced AI-powered features and digital image capture capabilities. The company's Ultrasound-on-Chip™ technology aims to make ultrasound imaging more affordable, sustainable, and scalable, leveraging Moore's Law to deliver increasingly powerful and cost-effective imaging tools.
Butterfly Network (NYSE: BFLY), a digital health company specializing in handheld ultrasound technology, has announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024, in New York City. CEO Joseph DeVivo and CFO Heather Getz will conduct one-on-one meetings throughout the event. DeVivo will present a business overview at 11:00 am ET. The presentation will be available via webcast on the company's investor website until February 19, 2025.
Butterfly Network (NYSE: BFLY) reported strong Q3 2024 results with revenue of $20.6 million, up 33% year-over-year. The company reduced its net loss by 38% and net cash used in operations by 50%. Product revenue increased 55% to $13.5 million, while software and services revenue grew 5% to $7.0 million. The company launched iQ3 in Europe and expanded into Indonesia, the Netherlands, and Belgium. Based on strong performance, Butterfly raised its full-year 2024 guidance to $79-81 million in revenue and improved its adjusted EBITDA loss forecast to $42-40 million.
HeartFocus has launched its AI-powered Education app in partnership with Butterfly Network (NYSE: BFLY), designed to teach healthcare practitioners how to conduct clinical-grade heart scans using Butterfly's handheld ultrasound devices. The app helps users master 10 essential cardiac views through personalized, AI-powered learning pathways.
Compatible with Butterfly iQ3 and iQ+ probes on iOS iPads, the platform features advanced gamification for enhanced engagement. The app will be demonstrated at the ANCC MagPath 2024 conference and is currently available in the US and 22 other countries, with a -time offer of a free six-month license.
Butterfly Network, Inc. (NYSE: BFLY), a digital health company specializing in portable, semiconductor-based ultrasound technology, has announced its plans to report third quarter 2024 financial results on November 1, 2024, at 8:00 am ET. The company will host a conference call and webcast before market opening, featuring Joseph DeVivo, President, CEO, and Chairman of the Board, along with Heather Getz, EVP and CFO/COO.
The conference call will be broadcast live in listen-only mode via a webcast on Butterfly's Investor Relations website. Interested parties can also dial in to listen to the call. A replay of the call will be available until November 15, 2024, through various access methods provided in the announcement.
Kansas City University (KCU) is pioneering point-of-care ultrasound (POCUS) education by introducing a first-of-its-kind, hands-on POCUS elective in its 2024 curriculum. KCU is the first U.S. medical school to use Butterfly Network's AI-guided ScanLab™ application as the foundation of its POCUS curriculum. The program focuses on student scanning proficiency, ensuring graduates are prepared for residency and clinical settings.
The AI-powered ScanLab™ app provides real-time feedback, anatomical labeling, and grading, enabling students to learn independently. Nearly 300 students have enrolled in KCU's POCUS elective series, using personal Butterfly handheld ultrasound devices. This innovative approach addresses the gap in POCUS training in medical schools, setting a new standard for medical education in the 21st century.
Butterfly Network, Inc. (NYSE: BFLY) has published a case study highlighting the successful implementation of its point-of-care ultrasound (POCUS) devices and Compass™ workflow software at the University of Rochester Medical Center (URMC). The deployment resulted in a 116% increase in ultrasound charge capture across the health system. URMC has deployed 862 Butterfly devices across 64 departments and plans to scale to 2,500 devices by 2026.
Key achievements include:
- Nearly 50,000 scanning sessions completed since 2022
- 74% increase in scanning sessions in 2023
- 147% rise in studies uploaded from Butterfly devices
- 1,782% jump in images uploaded from non-Butterfly devices
These results have contributed to earlier diagnoses and improved patient outcomes while reducing emergency visits.
Butterfly Network (NYSE:BFLY) has been named one of 2024's Fierce 50 honorees by Fierce Life Sciences and Fierce Healthcare. This recognition highlights Butterfly's advancements in medical imaging through its portable, semiconductor-based ultrasound technology. Key achievements include:
1. The successful launch of the next-generation Butterfly iQ3™
2. Establishment of the Butterfly Garden™ program for ultrasound AI innovation
3. Creation of a chip-licensing program for partners to develop technologies Powered by Butterfly™
CEO Joseph DeVivo emphasized the company's mission to democratize medical imaging by improving access, affordability, and sustainability. The Fierce 50 recognition underscores Butterfly's role in driving digital revolution in the ultrasound industry.
FAQ
What is the current stock price of Butterfly Network (BFLY)?
What is the market cap of Butterfly Network (BFLY)?
What is Butterfly Network, Inc.?
What product does Butterfly Network offer?
How does the Butterfly iQ+ work?
What makes Butterfly Network's technology unique?
Who funds Butterfly Network?
What are the recent achievements of Butterfly Network?
How does Butterfly Network contribute to healthcare?
Is Butterfly Network publicly traded?
Can the Butterfly iQ+ be used in multiple medical settings?
Where can I find the latest news on Butterfly Network?
